Equity Distribution Agreements in the Biotechnology Industry

66 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Equity Distribution Agreement, dated November 26, 2018, by and between Idera Pharmaceuticals, Inc. and JMP Securities LLC
Equity Distribution Agreements
IDERA PHARMACEUTICALS, INC.
Biotechnology
DE
2018
Equity Distribution Agreement, dated July 26, 2024, by and between Aileron Therapeutics, Inc. and Citizens JMP Securities, LLC
Equity Distribution Agreements
AILERON THERAPEUTICS INC
2024
Amendment No. 1 to the Equity Distribution Agreement, dated July 11, 2024, by and between Nurix Therapeutics, Inc. and Piper Sandler & Co
Equity Distribution Agreements
Nurix Therapeutics, Inc.
2024
Equity Distribution Agreement, dated July 1, 2024, by and between Biora Therapeutics, Inc., Canaccord Genuity LLC and H.C. Wainwright & Co., LLC
Equity Distribution Agreements
PROGENITY, INC.
2024
Equity Distribution Agreement, dated as of April 19, 2023, by and between AIM Immunotech Inc. and Maxim Group LLC
Equity Distribution Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2023
Equity Distribution Agreement, dated April 12, 2023, between Palatin Technologies, Inc. and Canaccord Genuity LLC
Equity Distribution Agreements
PALATIN TECHNOLOGIES INC
Biotechnology
NY
2023
Equity Distribution Agreement, dated as of March 27, 2023, by and between Edesa Biotech, Inc. and Canaccord Genuity LLC
Equity Distribution Agreements
Stellar Biotechnologies, Inc.
Biotechnology
NY
2023
Equity Distribution Agreement, dated January 23, 2023, by and between the Company and Maxim Group LLC
Equity Distribution Agreements
YIELD10 BIOSCIENCE, INC.
Biotechnology
NY
2023
Amendment No. 1 to Equity Distribution Agreement, dated December 19, 2022, by and among Clene Inc. and Canaccord Genuity LLC and Oppenheimer & Co. Inc
Equity Distribution Agreements
Chelsea Worldwide Inc.
Biotechnology
2022
Equity Distribution Agreement, dated December 9, 2022, among Aptose Biosciences Inc. and JonesTrading Institutional Services LLC
Equity Distribution Agreements
Aptose Biosciences Inc.
Biotechnology
CA
2022
Equity Distribution Agreement, dated November 18, 2022 by and among Genprex, Inc. and JMP Securities LLC
Equity Distribution Agreements
Genprex, Inc.
Biotechnology
DE
2022
Equity Distribution Agreement, dated November 7, 2022, by and between Amicus Therapeutics, Inc. and Goldman Sachs & Co. LLC
Equity Distribution Agreements
AMICUS THERAPEUTICS, INC.
Biotechnology
NY
2022
Equity Distribution Agreement, dated August 12, 2022, by and between Piper Sandler & Co. and the Registrant
Equity Distribution Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
NY
2022
Equity Distribution Agreement, dated as of June 22, 2022, by and between bluebird bio, Inc. and Goldman Sachs & Co. LLC
Equity Distribution Agreements
bluebird bio, Inc.
Biotechnology
NY
2022
Equity Distribution Agreement, dated May 16, 2022, by and between Inhibikase Therapeutics, Inc. and Piper Sandler & Co
Equity Distribution Agreements
Inhibikase Therapeutics, Inc.
Biotechnology
NY
2022
Equity Distribution Agreement, dated April 14, 2022, by and among Clene Inc. and Canaccord Genuity LLC and Oppenheimer & Co. Inc
Equity Distribution Agreements
Chelsea Worldwide Inc.
Biotechnology
NY
2022
Equity Distribution Agreement, dated April 8, 2022, by and between Vyant Bio, Inc. and Canaccord Genuity LLC
Equity Distribution Agreements
CANCER GENETICS, INC
Biotechnology
NY
2022
First Amendment to Equity Distribution Agreement, dated as of March 4, 2022, by and between Edesa Biotech, Inc. and RBC Capital Markets, LLC
Equity Distribution Agreements
Stellar Biotechnologies, Inc.
Biotechnology
2022
Equity Distribution Agreement between the Company and Goldman Sachs & Co. LLC, SVB Securities LLC and Cantor Fitzgerald & Co., dated as of February 28, 2022
Equity Distribution Agreements
Denali Therapeutics Inc.
Biotechnology
NY
2022
Equity Distribution Agreement, dated January 26, 2022, by and between the Company and Cowen and Company, LLC
Equity Distribution Agreements
Applied Therapeutics Inc.
Biotechnology
NY
2022
Equity Distribution Agreement, dated as of December 10, 2021, between Frequency Therapeutics, Inc. and Oppenheimer & Co. Inc
Equity Distribution Agreements
Frequency Therapeutics, Inc.
Biotechnology
NY
2021
Equity Distribution Agreement, dated as of November 22, 2021, by and between Edesa Biotech, Inc. and RBC Capital Markets, LLC
Equity Distribution Agreements
Stellar Biotechnologies, Inc.
Biotechnology
NY
2021
Equity Distribution Agreement, dated November 10, 2021 by and between PhaseBio Pharmaceuticals, Inc. and William Blair & Company, L.L.C
Equity Distribution Agreements
PhaseBio Pharmaceuticals Inc
Biotechnology
NY
2021
Equity Distribution Agreement, dated as of October 15, 2021, between Catalyst Biosciences, Inc. and Piper Sandler & Co
Equity Distribution Agreements
CATALYST BIOSCIENCES, INC.
Biotechnology
NY
2021
Equity Distribution Agreement, dated as of August 16, 2021, between Cyclo Therapeutics, Inc. and Oppenheimer & Co. Inc
Equity Distribution Agreements
CTD HOLDINGS INC
Biotechnology
NY
2021
Equity Distribution Agreement, dated February 25, 2021, by and among Altimmune, Inc. and Piper Sandler & Co., Evercore Group L.L.C. and B. Riley Securities, Inc
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
NY
2021
Equity Distribution Agreement, dated as of December 23, 2020, by and between Biohaven Pharmaceutical Holding Company Ltd. and Goldman Sachs & Co. LLC, Piper Sandler & Co., SVB...
Equity Distribution Agreements
Biohaven Pharmaceutical Holding Co Ltd.
Biotechnology
NY
2020
Equity Distribution Agreement, dated December 14, 2020, between Aptevo Therapeutics Inc. and Piper Sandler & Co
Equity Distribution Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2020
Equity Distribution Agreement, dated as of September 28, 2020, by and between Edesa Biotech, Inc. and RBC Capital Markets, LLC
Equity Distribution Agreements
Stellar Biotechnologies, Inc.
Biotechnology
NY
2020
Equity Distribution Agreement, dated as of September 25, 2020, by and between Atossa Therapeutics, Inc. and Maxim Group LLC
Equity Distribution Agreements
ATOSSA GENETICS INC
Biotechnology
NY
2020
Equity Distribution Agreement between Cellectar Biosciences, Inc. and Oppenheimer & Co. Inc., dated August 11, 2020
Equity Distribution Agreements
Cellectar Biosciences, Inc.
Biotechnology
NY
2020
Amendment No. 1 to Equity Distribution Agreement, dated July 29, 2020, by and between iBio, Inc. and UBS Securities LLC
Equity Distribution Agreements
iBio, Inc.
Biotechnology
NY
2020
Equity Distribution Agreement, dated June 17 2020, by and between iBio, Inc. and UBS Securities, LLC
Equity Distribution Agreements
iBio, Inc.
Biotechnology
NY
2020
Equity Distribution Agreement, dated May 13, 2020, by and among Alector, Inc., Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC
Equity Distribution Agreements
Alector, Inc.
Biotechnology
CA
2020
Equity Distribution Agreement, dated May 5, 2020, among Aptose Biosciences Inc., Piper Sandler & Co. and Canaccord Genuity LLC
Equity Distribution Agreements
Aptose Biosciences Inc.
Biotechnology
CA
2020
Amendment No. 2 to Equity Distribution Agreement dated as of April 8, 2020 by and between T2 Biosystems, Inc. and Canaccord Genuity LLC
Equity Distribution Agreements
T2 Biosystems, Inc.
Biotechnology
2020
Equity Distribution Agreement between Isoray, Inc. and Oppenheimer & Co. Inc., dated March 31, 2020
Equity Distribution Agreements
Isoray, Inc.
Biotechnology
NY
2020
Equity Distribution Agreement, dated March 27, 2020, by and among Altimmune, Inc. and JMP Securities LLC
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
DE
2020
Equity Distribution Agreement, dated March 20, 2020
Equity Distribution Agreements
OncoCyte Corp
Biotechnology
NY
2020
Amendment No. 1 to Equity Distribution Agreement dated as of March 9, 2020 by and between T2 Biosystems, Inc. and Canaccord Genuity LLC
Equity Distribution Agreements
T2 Biosystems, Inc.
Biotechnology
2020
Amended and Restated Equity Distribution Agreement, dated March 4, 2020, by and among the Company, Citigroup Global Markets Inc. and SVB Leerink LLC
Equity Distribution Agreements
Millendo Therapeutics, Inc.
Biotechnology
NY
2020